Huihui Yu

Huihui Yu

Auto-generated profile, based on publicly available information

Huihui Yu

Center for Outcomes Research and Evaluation, Section of Cardiovascular Medicine, Yale School of Medicine , New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Journal of School Psychology
Verified
Journal Article
Closed access
FMFaith G. Miller
Faith G. Miller
AJAustin H. Johnson
Austin H. Johnson
HYHuihui Yu
Huihui Yu
SCSandra Chafouleas
Sandra Chafouleas
DMD. Betsy McCoach
D. Betsy McCoach
MWMegan Welsh
Megan Welsh

15 July 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KBKevin Bozic
Kevin Bozic
HYHuihui Yu
Huihui Yu
MZMichael G. Zywiel
Michael G. Zywiel
LLLi Li
Li Li
ZLZhenqiu Lin
Zhenqiu Lin
LSLisa G. Suter
Lisa G. Suter
Background: Given the inclusion of orthopaedic quality measures in the Centers for Medicare & Medicaid Services national hospital payment programs, the present study sought to assess whether the public reporting of total hip arthroplasty (THA) and total knee arthroplasty (TKA) risk-standardized readmission rates (RSRRs) and complication rates (RSCRs) was temporally associated with a decrease in the rates of these outcomes among Medicare beneficiaries. Methods: Annual trends in national observed and hospital-level RSRRs and RSCRs were evaluated for patients who underwent hospital-based inpatient hip and/or knee replacement procedures from fiscal year 2010 to fiscal year 2016. Hospital-level rates were calculated with use of the same measures and methodology that were utilized in public reporting. Annual trends in the distribution of hospital-level outcomes were then examined with use of density plots. Results: Complication and readmission rates and variation declined steadily from fiscal year 2010 to fiscal year 2016. Reductions of 33% and 25% were noted in hospital-level RSCRs and RSRRs, respectively. The interquartile range decreased by 18% (relative reduction) for RSCRs and by 34% (relative reduction) for RSRRs. The frequency of risk variables in the complication and readmission models did not systematically change over time, suggesting no evidence of widespread bias or up-coding. Conclusions: This study showed that hospital-level complication and readmission rates following THA and TKA and the variation in hospital-level performance declined during a period coinciding with the start of public reporting and financial incentives associated with measurement. The consistently decreasing trend in rates of and variation in outcomes suggests steady improvements and greater consistency among hospitals in clinical outcomes for THA and TKA patients in the 2016 fiscal year compared with the 2010 fiscal year. The interactions between public reporting, payment, and hospital coding practices are complex and require further study. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

31 May 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
LWLauren E Wisk
Lauren E Wisk
MGMichael Gottlieb
Michael Gottlieb
PCPeizheng Chen
Peizheng Chen
HYHuihui Yu
Huihui Yu
KOKelli N O’lAughlin
Kelli N O’lAughlin
RWRobert A Weinstein
Robert A Weinstein
Background: Long-term sequelae after SARS-CoV-2 infection may impact health-related quality-of-life (HRQoL), yet it is unknown how HRQoL changes during recovery. We compared patient-reported HRQoL among adults with COVID-19–like illness who tested SARS-CoV-2 positive (COVID+) with those who tested negative (COVID−). Methods: Participants in this prospective, multicenter, longitudinal registry study were enrolled from December 2020 through August 2022 and completed 3-month follow-up assessments until 12 months after enrollment. Participants were adults (≥18 years) with acute symptoms suggestive of COVID-19 who received a Food and Drug Administration–approved SARS-CoV-2 test. Participants received questions from PROMIS-29 (subscales: physical function, anxiety, depression, fatigue, social participation, sleep disturbance, and pain interference) and PROMIS SF-8a (cognitive function). Latent transition analysis was used to identify meaningful patterns in HRQoL scores over time; 4 HRQoL categories were compared descriptively and using multivariable regression. Inverse probability weighting was used to adjust for covariate imbalance. Results: There were 1096 (75%) COVID+ and 371 (25%) COVID−. Four distinct well-being classes emerged: optimal overall, poor mental, poor physical, and poor overall HRQoL. COVID+ participants were more likely to return to the optimal HRQoL class compared to COVID− participants. The most substantial transition from poor physical to optimal HRQoL occurred by 3 months, whereas movement from poor mental to optimal HRQoL occurred by 9 months. Conclusions: In adults with COVID-19–like illness, COVID+ participants demonstrated meaningful recovery in their physical HRQoL by 3 months after infection, but mental HRQoL took longer to improve. Suboptimal HRQoL at 3 to 12 months after infection remained in approximately 20%. Trial Registration: NCT04610515.

18 June 2025 in Clinical Infectious Diseases
Verified
Journal Article
Open access
JOJohn Openshaw
John Openshaw
JCJi Chen
Ji Chen
RRRobert Rodriguez
Robert Rodriguez
MGMichael Gottlieb
Michael Gottlieb
KMKalyani McCullough
Kalyani McCullough
JEJoann Elmore
Joann Elmore
Background: The clinical consequences of repeated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not clear, especially as they relate to long-term symptoms after infection. We analyzed data collected for the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) to determine whether reinfection changes the likelihood of symptoms 3–6 months after reinfection compared with the likelihood in individuals experiencing a single infection. Methods: Individuals reporting a single SARS-CoV-2 infection or a single reinfection were included in this analysis. A positive SARS-CoV-2 test occurring ≥90 days after a first infection was considered a reinfection. Outcomes included severe fatigue (fatigue severity score ≥25) and the presence of organ system symptoms 3–6 months after the last infection. Results: The analysis included 886 individuals, 415 (46.8%) of whom experienced reinfection. For individuals who experienced their first infections in either the pre-Delta or Delta periods, the odds of having ≥3 symptoms 3–6 months after their most recent infection was lower in those reinfected than those with a single infection (weighted adjusted odds ratio, 0.45 [95% confidence interval, .21–.95] and 0.51 [.32–.79], respectively). However, in individuals reporting their first infection during the Omicron wave, the odds of reporting ≥3 symptoms after the most recent infection was higher in those reinfected than in those with a single infection (weighted adjusted odds ratio, 1.54 [95% confidence interval, 1.02–2.34]). Conclusions: The timing of initial infection, reinfection, and the variants involved may play important roles in longer-term clinical outcomes. Repeated infection with Omicron variants may increase the risk of long-term symptoms.

1 October 2022 in Psychological Assessment
Verified
Journal Article
Closed access
HYHuihui Yu
Huihui Yu
KLKellina K. Lupas
Kellina K. Lupas
SCSandra Chafouleas
Sandra Chafouleas
DMD. Betsy McCoach
D. Betsy McCoach
GFGregory A. Fabiano
Gregory A. Fabiano
DVDaniel T. Volk
Daniel T. Volk
The growth of school-based initiatives incorporating multitiered systems of support (MTSS) for social, emotional, and behavioral domains has fueled interest in behavioral assessment. These assessments are foundational to determining risk for behavioral difficulties, yet research to date has been limited with regard to when and how often to administer them. The present study evaluated these questions within the framework of behavioral stability and examined the extent to which behavior is stable when measured by two school-based behavioral assessments: the Direct Behavior Rating-Single-Item Scales (DBR-SIS), and the Behavioral and Emotional Screening System (BESS). Participants included 451 students rated three times per year across 4 years, with the primary teacher from each year providing the within-year ratings. Latent variable models were employed to measure the constructs underlying the observed assessment scores. Models demonstrated that the DBR-SIS best captured changes within the year, whereas the BESS scores remained stable across time points within a year. Across years, scores from both assessments captured changes. The unique contributions of each assessment in the data-based decision-making process are discussed, and recommendations are given for their combined use within and across school years. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

22 August 2024 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Open access
PDF file
Mandy J HillMandy J Hill
Mandy J Hill
RHRyan M. Huebinger
Ryan M. Huebinger
IMImtiaz Ebna Mannan
Imtiaz Ebna Mannan
HYHuihui Yu
Huihui Yu
LWLauren E. Wisk
Lauren E. Wisk
AVArjun Venkatesh
Arjun Venkatesh
Background: Differences in acute COVID-19 associated morbidity based on race, ethnicity, and gender have been well described; however, less is known about differences in subsequent longer term health-related quality of life and well-being. Methods: This prospective cohort study included symptomatic adults tested for SARS-CoV-2 who completed baseline and 3-month follow-up surveys. Using the PROMIS-29 tool, a validated measure of health and well-being, we compared outcomes at 3 months and change in outcomes from baseline to 3 months among groups with different races, ethnicities, and/or sexes. Results: Among 6044 participants, 4113 (3202 COVID +) were included. Among COVID + participants, compared to non-Hispanic White participants, Black participants had better PROMIS T-scores for cognitive function (3.6 [1.1, 6.2]) and fatigue (− 4.3 [− 6.6, − 2.0]) at 3 months and experienced more improvement in fatigue over 3 months (− 2.7 [− 4.7, − 0.8]). At 3 months, compared with males, females had worse PROMIS T-scores for cognitive function (− 4.1 [− 5.6, − 2.6]), physical function (− 2.1 [− 3.1, − 1.0]), social participation (− 2.8 [− 4.2, − 1.5]), anxiety (2.8 [1.5, 4.1]), fatigue (5.1 [3.7, 6.4]), and pain interference (2.0 [0.9, 3.2]). Females experienced less improvement in fatigue over 3 months (3.1 [2.0, 4.3]). Transgender/non-binary/other gender participants had worse 3-month scores in all domains except for sleep disturbance and pain interference. Conclusions: Three months after the initial COVID-19 infection, Black participants reported better cognitive function and fatigue, while females and other gender minoritized groups experienced lower well-being. Future studies are necessary to better understand how and why social constructs, specifically race, ethnicity, and gender, influence differences in COVID-19-related health outcomes. Trials Registration ClinicalTrials.gov Identifier: NCT04610515